Phase II Study (ongoing, recruiting)

Official Title:A randomised, double blind, placebo controlled study to evaluate the micro-macroscopic effects on muscles, the safety and tolerability, and the efficacy of Givinostat in patients with Becker Muscular Dystrophy (DSC/14/2357/53).

Purpose: The main objective of the study is to evaluate whether the beneficial histological effects observed with Givinostat in the DMD patients could be extended to Becker patients.